ANIK
Anika Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$20.81
−0.90%Forward multiples
Based on analyst estimates
- P/E forward
- 30.60x
- P/E 2026E
- 39.74x
- P/E 2027E
- 28.65x
- P/E 2028E
- 18.31x
- P/S forward
- 2.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.03x
- Price / sales
- 2.31x
- Price / cash flow
- 46.60x
Enterprise value
- Enterprise value
- $263.4M
- EV / sales
- 2.18x
- EV / EBITDA
- 96.95x
- EV / EBIT
- -51.44x
- Market cap
- $278.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026